PMID- 21937446 OWN - NLM STAT- MEDLINE DCOM- 20111227 LR - 20211020 IS - 1083-351X (Electronic) IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 286 IP - 45 DP - 2011 Nov 11 TI - Intranodal interaction with dendritic cells dynamically regulates surface expression of the co-stimulatory receptor CD226 protein on murine T cells. PG - 39153-63 LID - 10.1074/jbc.M111.264697 [doi] AB - Dendritic cells (DCs) are the most potent antigen-presenting cells of the immune system. Depending on their maturation status, they prime T cells to induce adaptive immunity or tolerance. DCs express CD155, an immunoglobulin-like receptor binding CD226 present on T and natural killer (NK) cells. CD226 represents an important co-stimulator during T cell priming but also serves as an activating receptor on cytotoxic T and NK cells. Here, we report that cells of the T and NK cell lineage of CD155(-/-) mice express markedly elevated protein levels of CD226 compared with wild type (WT). On heterozygous CD155(+/-) T cells, CD226 up-regulation is half-maximal, implying an inverse gene-dosis effect. Moreover, CD226 up-regulation is independent of antigen-driven activation because it occurs already in thymocytes and naive peripheral T cells. In vivo, neutralizing anti-CD155 antibody elicits up-regulation of CD226 on T cells demonstrating, that the observed modulation can be triggered by interrupting CD155-CD226 contacts. Adoptive transfers of WT or CD155(-/-) T cells into CD155(-/-) or WT recipients, respectively, revealed that CD226 modulation is accomplished in trans. Analysis of bone marrow chimeras showed that regulators in trans are of hematopoietic origin. We demonstrate that DCs are capable of manipulating CD226 levels on T cells in vivo but not in vitro, suggesting that the process of T cells actively scanning antigen-presenting DCs inside secondary lymphoid organs is required for CD226 modulation. Hence, a CD226 level divergent from WT may be exploited as a sensor to detect abnormal DC/T-cell cross-talk as illustrated for T cells in mice lacking CCR7. FAU - Seth, Sebastian AU - Seth S AD - Institute of Immunology, Hannover Medical School, D-30625 Hannover, Germany. FAU - Qiu, Quan AU - Qiu Q FAU - Danisch, Simon AU - Danisch S FAU - Maier, Michael K AU - Maier MK FAU - Braun, Asolina AU - Braun A FAU - Ravens, Inga AU - Ravens I FAU - Czeloth, Niklas AU - Czeloth N FAU - Hyde, Rebecca AU - Hyde R FAU - Dittrich-Breiholz, Oliver AU - Dittrich-Breiholz O FAU - Forster, Reinhold AU - Forster R FAU - Bernhardt, Gunter AU - Bernhardt G LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110921 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Antibodies, Neutralizing) RN - 0 (Antigens, Differentiation, T-Lymphocyte) RN - 0 (CD226 antigen) RN - 0 (Ccr7 protein, mouse) RN - 0 (Receptors, CCR7) RN - 0 (Receptors, Virus) RN - 0 (poliovirus receptor) SB - IM MH - Adoptive Transfer MH - Animals MH - Antibodies, Neutralizing/pharmacology MH - Antigens, Differentiation, T-Lymphocyte/biosynthesis/genetics/*immunology MH - Cell Communication/drug effects/genetics/*immunology MH - Dendritic Cells/cytology/*immunology/metabolism MH - Lymph Nodes/cytology/*immunology/metabolism MH - Mice MH - Mice, Inbred BALB C MH - Mice, Knockout MH - Receptors, CCR7/genetics/immunology/metabolism MH - Receptors, Virus/antagonists & inhibitors/genetics/immunology/metabolism MH - T-Lymphocytes/cytology/*immunology/metabolism MH - Up-Regulation/drug effects/genetics/*immunology PMC - PMC3234740 EDAT- 2011/09/23 06:00 MHDA- 2011/12/28 06:00 PMCR- 2012/11/11 CRDT- 2011/09/23 06:00 PHST- 2011/09/23 06:00 [entrez] PHST- 2011/09/23 06:00 [pubmed] PHST- 2011/12/28 06:00 [medline] PHST- 2012/11/11 00:00 [pmc-release] AID - S0021-9258(20)50574-7 [pii] AID - M111.264697 [pii] AID - 10.1074/jbc.M111.264697 [doi] PST - ppublish SO - J Biol Chem. 2011 Nov 11;286(45):39153-63. doi: 10.1074/jbc.M111.264697. Epub 2011 Sep 21.